Professor of Medicine (AIDS) and Associate Clinical Professor of Nursing; Director, Infectious Disease Outpatient Clinic, Veterans Administration Healthcare Services, Newington
InSTRIDE
Integrating Substance Use Treatment Research with Infectious Disease for Everyone
Our MISSION at InSTRIDE focuses on the intersection of substance use and infectious diseases. Current research focuses on treatments for opioid use disorder, specifically among persons with HIV and other infections, and the criminal justice population. Our mission is to improve the lives of persons with substance use disorder through both research and connecting people to community resources.
Dr. Sandra Springer works on the intersection of substance use and infectious disease:
- Appointed Member of the National Academies of Sciences Engineering Medicine (NASEM) Organizing Committee for Opportunities to Improve Opioid Use Disorder and Infectious Disease Services
- Member of the National Academies of Sciences Engineering Medicine (NASEM) Organizing Committee and author of Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics:A Report From the National Academies of Sciences, Engineering, and Medicine
- Co Author of American Society of Addiction Medicine (ASAM) Updated National Practice Guideline for Treating Opioid Use Disorder
- Author of Providers Clinical Support System (PCSS) Guidelines: Monitoring of Liver Function Tests in Patients Receiving Naltrexone or Extended-Release Naltrexone. Presenter for Advances in Non-Agonist Therapies SAMHSA (Page 16 of document)
- Co-writer for the Policy on Hepatitis C Diagnosis and Treatment Among Persons who use Drugs
- Clinical Care Options: Incorporating Opioid Use Disorder Screening and Treatment into HIV and HCV Management
- HIV/HCV Roundtable Video
- The Impact of the Opioid Epidemic on New Infectious Disease Epidemics: A Call to Action!
Follow Dr. Springer on Twitter: @SandySpringerMD
For more information contact us at:
877-55-HELPU (43578)
Leadership
- Sandra Springer, MD is the director of her clinical research lab InSTRIDE (Integrating Substance use Treatment Research with Infectious Disease for Everyone) which encompasses a multidisciplinary team including research staff, clinicians, community health workers, and patient navigators as well as a mobile health unit and a mobile pharmacy and clinic. In addition, she is a Professor of Medicine in the Department of Internal Medicine, Section of Infectious Diseases at the Yale School of Medicine. Dr. Springer is Board-Certified in Internal Medicine, Infectious Diseases and Addiction Medicine. She is also an attending physician at the Veterans Administration Connecticut Healthcare System (VACHS) and the Director of the Infectious Disease Clinic at the Newington site of the VACHS. She is an appointed member of the International Antiviral Society–USA (IAS–USA) Antiretroviral Guidelines Panel as well as a Core Faculty member and has been appointed to the National Academies of Sciences, Engineering, and Medicine’s Committee on Framework for the Consideration of Chronic Conditions in Women. She mentors students across disciplines including public health, medicine, and the social sciences. Her research centers on the integration of substance use and infectious diseases with a focus on opioid use treatment and the treatment and prevention of HIV infection in people with carceral experience. In 2022, she was awarded the NIDA Avant Garde award for her innovative proposal to bring mobile health care for substance use and infectious diseases to where people live, through a mobile pharmacy and clinic.
In the News
June 22, 2022
A new clinical trial, the ‘Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION)’ initiative, is currently recruiting participants.